scispace - formally typeset
P

Priyanjalee Banerjee

Researcher at Bose Corporation

Publications -  9
Citations -  511

Priyanjalee Banerjee is an academic researcher from Bose Corporation. The author has contributed to research in topics: Oxidative stress & Amyloid beta. The author has an hindex of 7, co-authored 8 publications receiving 389 citations.

Papers
More filters
Journal ArticleDOI

Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-κB Connection

TL;DR: The biology of NF-κB and its activation by reactive oxygen species (ROS) and proinflammatory cytokines in the pathogenesis of AD have been specially highlighted citing evidence both from post-mortem studies in AD brain and experimental research in animal or cell-based models of AD.
Journal ArticleDOI

Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.

TL;DR: The review suggests that the oxidative stress could be an early event in the disease process and may trigger various adaptive responses such as the alterations of amyloid beta metabolism and the activation of stress responsive kinases which can subsequently lead to neuronal degeneration and AD pathology.
Journal ArticleDOI

α‐synuclein‐induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease

TL;DR: It is suggested that intracellularly accumulated α‐synuclein can interact with mitochondria in intact SHSY5Y cells causing dysfunction of the organelle which drives the cell death under the authors' experimental conditions, which has clear implications in the pathogenesis of sporadic Parkinson's disease.
Journal ArticleDOI

Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein

TL;DR: Exogenously added iron in the form of ferric ammonium citrate leads to considerable accumulation of amyloid precursor protein (APP) without a corresponding change in the concerned gene expression in cultured SHSY5Y cells during exposure up to 48 h, providing the initial evidence of potential therapeutic effects of negletein.